ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCI Could Fund 840 Competing Grants Under Clinton Budget

April 16, 1993

In Brief: USC Study Finds Sedentary Occupations Increase Colon Cancer Risk for Men Over More Active Jobs

November 30, 1984

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992

NCI Clarifies IRPG Application Receipt, Funding Policies

September 3, 1993

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011